BioSpace News Archive

New research analyzes correlation between social and environmental conditions and health outcomes

VeraSci, a global clinical technology and research services company, announces multiple significant enhancements to Pathway, their proprietary eCOA platform.

Nursing leader and phlebotomy expert will lend expertise as advisors while medical technology veteran assumes role of Chief Commercial Officer

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that a clinical development program is underway with Novartis to bring to market a molecular test as a companion diagnostic to guide the use of the investigational compound BYL719 (alpelisib) in combination with fulvestrant for men and postmenopausal women living with PIK3CA mutated hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer.

Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that it will host an Investor Symposium in New York City on December 12, 2018.

IQVIA’s Innovative Technology, Advanced Analytics and Industry Expertise Demonstrate the Value of Its CORE to Industry Partners

Addition of industry veterans reflects ongoing board refreshment efforts and commitment to further diversification

Senior Management to Lead Castlight Complete Demo for Financial Community

Brian P. McVeigh has joined the company’s Board of Directors, bringing expertise to expand activities in business development and investment management.

Persona Debuts New Portal at the Cleveland Clinic 16th Annual Dr. Roizen’s Preventative and Integrative Medicine Longevity Conference, December 7-9 in Las Vegas